HuGE Literature Finder
Records
1
-
9
| Association between CYP2D6 phenotype and recurrence of Plasmodium vivax infection in south Korean patients. Malaria journal 2022 Oct 21 (1): 289. Choi Sungim, Choi Heun, Park Seong Yeon, Kwak Yee Gyung, Song Je Eun, Shin So Youn, Baek Ji Hyeon, Shin Hyun-Il, Cho Shin-Hyung, Lee Sang-Eun, Kwon Jeong-Ran, Park Sookkyung, Kim Miyoung, Oh Hong Sang, Kim Yong Chan, Kim Min Jae, Yeom Joon-S |
| The association of CYP2D6 gene polymorphisms in the full-length coding region with higher recurrence rate of vivax malaria in Yunnan Province, China. Malaria journal 2021 Mar 20 (1): 160. Huang Herong, Dong Ying, Xu Yanchun, Deng Yan, Zhang Canglin, Liu Shuping, Chen Mengni, Liu Y |
| Prevalence of CYP2D6 Genotypes and Predicted Phenotypes in a Cohort of Cambodians at High Risk for Infections with Plasmodium vivax. The American journal of tropical medicine and hygiene 2020 May . Spring Michele D, Lon Chanthap, Sok Somethy, Sea Darapiseth, Wojnarski Mariusz, Chan Soklyda, Kuntawunginn Worachet, Keng Heng Thay, Nou Samon, Arsanok Montri, Sriwichai Sabaithip, Vanachayangkul Pattaraporn, Lin Jessica, Manning Jessica E, Jongsakul Krisada, Pichyangkul Sathit, Satharath Prom, Smith Philip L, Dysoley Lek, Saunders David L, Waters Norman |
| Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial. Malaria journal 2019 Jun 18 (1): 209. Raman Jaishree, Allen Elizabeth, Workman Lesley, Mabuza Aaron, Swanepoel Hendrik, Malatje Gillian, Frean John, Wiesner Lubbe, Barnes Karen |
| Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria. JAMA network open 2018 Aug 1 (4): e181449. Baird J Kevin, Louisa Melva, Noviyanti Rintis, Ekawati Lenny, Elyazar Iqbal, Subekti Decy, Chand Krisin, Gayatri Anggi, Instiaty , Soebianto Saraswati, Crenna-Darusallam Chelzie, Djoko Dwi, Hasto Bambang Dwi, Meriyenes Dubel, Wesche David, Nelwan Erni J, Sutanto Inge, Sudoyo Herawati, Setiabudy Rian |
| Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa. Malaria journal 2018 Mar 17 (1): 120. Awandu Shehu S, Raman Jaishree, Makhanthisa Takalani I, Kruger Philip, Frean John, Bousema Teun, Niemand Jandeli, Birkholtz Lyn-Mar |
| CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study. Malaria journal 2018 Feb 17 (1): 57. Brasil Larissa W, Rodrigues-Soares Fernanda, Santoro Ana B, Almeida Anne C G, Kühn Andrea, Ramasawmy Rajendranath, Lacerda Marcus V G, Monteiro Wuelton M, Suarez-Kurtz Guilher |
| Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrobial agents and chemotherapy 2013 Feb 57 (2): 950-8. Staehli Hodel Eva Maria, Csajka Chantal, Ariey Frédéric, Guidi Monia, Kabanywanyi Abdunoor Mulokozi, Duong Socheat, Decosterd Laurent Arthur, Olliaro Piero, Beck Hans-Peter, Genton Blai |
| Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. European journal of clinical pharmacology 2009 Apr 65 (4): 355-63. Veiga M I, Asimus S, Ferreira P E, Martins J P, Cavaco I, Ribeiro V, Hai T N, Petzold M G, Björkman A, Ashton M, Gil J |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 02, 2022
- Content source: